Here's Why You Should Retain McKesson Stock in Your Portfolio Now
MCK's strategic collaborations and strength in Biologics raise optimism about the stock.
Why McKesson (MCK) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
McKesson - Meet The New Dividend Stock On My Watchlist
McKesson's recent sell-off offers a compelling opportunity, driven by its strong position in healthcare distribution and growing focus on AI and technology for sustainable growth. The company boasts solid revenue and EPS growth, supported by AI integration, expansion into high-demand sectors like GLP-1 and oncology, and a robust business model. Shareholder returns are enhanced by aggressive buyback plans, a 15% dividend hike, and a healthy balance sheet, despite a low 0.6% dividend yield.
McKesson (MCK) Exceeds Market Returns: Some Facts to Consider
McKesson (MCK) reachead $518.81 at the closing of the latest trading day, reflecting a +1.49% change compared to its last close.
McKesson (MCK) Rises Yet Lags Behind Market: Some Facts Worth Knowing
McKesson (MCK) concluded the recent trading session at $511.17, signifying a +0.14% move from its prior day's close.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson, News Corporation And 2 Other Stocks Executives Are Selling
The Nasdaq 100 closed lower by over 500 points during Friday's session. Investors, meanwhile, focused on some notable insider trades.
McKesson Shares Fall Following Sale of Rexall, Well.ca to Birch Hill
MCK announces the sale of its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, aligning with its strategy to grow oncology and biopharma services.
S&P 500 Gains and Losses Today: McKesson Falls Amid Plans To Exit Canada Businesses
Major U.S. equities indexes were mixed as the latest ADP jobs data showed a smaller-than-expected jump in private payrolls in August.
Drug distributor McKesson forecasts Q2 profit below estimates
Drug distributor McKesson on Thursday forecast second-quarter profit below Wall Street estimates.
McKesson Corporation (MCK) Wells Fargo 2024 Healthcare Conference (Transcript)
McKesson Corporation (NYSE:MCK ) Wells Fargo 2024 Healthcare Conference September 5, 2024 8:45 AM ET Company Participants Britt Vitalone - Executive Vice President and Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Stephen Baxter Good morning. I'm Steve Baxter, the Healthcare Services Analyst at Wells Fargo.
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
